Skip to main content

Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers

IHV 17th Annual International Meeting

Nobel Laureate Harald zur Hausen and NIAID Director Anthony Fauci to receive Lifetime Achievement Awards

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland. The annual meeting is attended by internationally renowned scientists and integrates a multidisciplinary program of basic research including finding a cure for HIV, innovating and guiding development of an effective preventive HIV vaccine, and the study of HIV pathogenesis, hepatitis C and Ebola. Scientists are focusing on viruses and cancer to inform basic and translational research aimed at developing treatments while clinical research presentations are emphasizing opportunities to cure hepatitis C with newly available treatments. Global health presentations are focusing on translating discovery into public health practice.

During a gala at the meeting tonight, two 2015 IHV Lifetime Achievement Awards for Scientific Contributions and Public Service will each be rewarded to Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases and Nobel Laureate Harald zur Hausen, MD.

“Each year, our annual meeting attracts many of the best and brightest established and up and coming researchers medical virology has to offer because of the high caliber data presented during these meetings,” said Robert C. Gallo MD, Homer & Martha Gudelsky Distinguished Professor in Medicine, Director, Institute of Human Virology, University of Maryland School of Medicine, who is most widely known for his co-discovery of HIV as the cause of AIDS and, along with his coworkers, for the development of the HIV blood test.

Dr. Gallo continued, “I am especially pleased to be honoring two distinguished friends and colleagues for their significant scientific contributions to bettering human health and for their impactful worldwide public service. Since the beginning of the HIV epidemic, Tony Fauci has led many research and education efforts that have contributed tremendously in putting an end to AIDS. He has administered a comprehensive research portfolio targeting the prevention, detection, and treatment of infectious diseases, which is not limited to HIV,” said Dr. Gallo. “Harald zur Hausen’s pioneering research in human papillomaviruses, most notably in showing the link between human papillomaviruses (HPV) and cervical cancer, has contributed greatly to fighting cancer. His discoveries helped lead to the development of the HPV vaccine.”

In 1996 Dr. Gallo co-founded the IHV with colleagues William Blattner, MD and Robert Redfield, MD. The Baltimore-based Institute has cared for more than 1,000,000 HIV positive individuals in 7 African and 2 Caribbean nations in addition to approximately 6,000 HIV positive Baltimoreans. IHV is internationally renowned for its basic science research, which includes the search for a functional cure and a promising preventive HIV vaccine candidate funded largely by the Bill & Melinda Gates Foundation.

For more information, visit www.ihv.org and follow us on Twitter @IHVmeeting2015 and #IHVmeeting.

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Tuesday, December 12, 2017

    A Statement from the Leadership of the Institute of Human Virology on the Passing of Stewart Greenebaum

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine mourns the passing of Stewart Greenebaum, a lifelong Baltimore resident, former president of Greenebaum and Rose Associates, and past chairman of the IHV Board of Advisors, as well as a guiding force in the establishment of the IHV at the University of Maryland, Baltimore.


    Wednesday, November 29, 2017

    To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.


    Tuesday, November 22, 2016

    IHV Awarded $138M to combat HIV/AIDS in Africa & Launches Center for International Health, Education, & Biosecurity

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today more than $138 million in multiple five-year grants awarded by the Centers for Disease Control and Prevention to combat HIV/AIDS in Kenya, Tanzania, Zambia, and Nigeria. The Institute concurrently announced the formation of the IHV Center for International Health, Education, & Biosecurity (CIHEB), and its newly appointed director, Deus Bazira Mubangizi, DrPH, MBA, MPH, Assistant Professor of Medicine, Director, Center for Health, Education, & Biosecurity, Institute of Human Virology, University of Maryland School of Medicine.


    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.


    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.


    Wednesday, April 13, 2016

    IHV Releases Data Supporting Community-Based Treatment Providers in Fight Against Hepatitis C

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine released data today at The International Liver Congress 2016 in Barcelona, Spain demonstrating that treatment for hepatitis C virus (HCV) can be provided safely and effectively within a community-based and non-specialist setting.


    Thursday, March 10, 2016

    UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.


    Tuesday, December 01, 2015

    A Statement from the Leadership of the Institute of Human Virology on World AIDS Day

    Research enabled treatment to be developed for HIV/AIDS, allowing the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (which Dr. Gallo heads and co-founded with his colleagues Drs. William Blattner and Robert Redfield) to develop a promising HIV vaccine candidate, treat nearly 6,000 patients annually in Baltimore, and care for more than 1 million people in Africa and the Caribbean since 2004.


Comment on this Story

Comment on this Story